Sovereign Nations. Different Laws. One Complicated Payments System.
Sovereign Nations. Different Laws. One Complicated Payments System. On Indigenous Peoples' Day, it's time to examine why tribal gaming, ...
New York’s legal cannabis industry is facing renewed scrutiny following a sweeping $30 million product recall and allegations of improper licensing practices tied to Long Island-based Omnium Health Inc., also known as Omnium Canna. The controversy has reignited questions about transparency, enforcement, and compliance oversight in one of the nation’s most closely watched cannabis markets.
On October 20, 2025, the state’s Office of Cannabis Management (OCM) filed multiple charges against Omnium Health, alleging the company allowed unlicensed operators to use its licensed processing and distribution facilities. Regulators say this practice amounted to a “reverse licensing” or “rent-a-license” arrangement—allowing out-of-state brands to produce and sell cannabis products in New York without authorization.
The OCM’s enforcement notice seeks to revoke Omnium’s licenses, ban the company from future participation in the state’s cannabis market, and impose civil penalties tied to the value of unregulated products sold. It also ordered a statewide recall of all products linked to Omnium—an estimated $30 million worth of cannabis goods.
Oregon-based edibles producer Grön was among the companies named in reports surrounding the alleged licensing scheme. The brand has strongly denied any wrongdoing, calling the OCM’s claims “inaccurate and misleading.”
In a statement published by The New York Times, Grön said it had “fully disclosed” its short-term partnership with Omnium more than a year ago and that it complied with all OCM requirements. The company also emphasized that none of its products were affected by the recall, adding that its reputation had been “unfairly tarnished” by association.
Industry observers note that the lack of a clear recall process has left dispensaries and wholesalers uncertain about how to proceed. As of early November, the OCM had yet to issue detailed guidance clarifying which products are affected or how the recall will be executed.
The controversy underscores broader challenges within New York’s regulatory system. Nearly three years after the state launched legal cannabis sales, it still lacks a functional track-and-trace system capable of monitoring products from cultivation to retail.
The OCM has announced plans to integrate Metrc’s seed-to-sale tracking software by December 2025, but until then, regulators must depend on companies’ internal documentation to manage recalls and verify compliance. This manual process increases the risk of error, delays enforcement, and erodes public confidence in the state’s oversight framework.
For retailers, the lack of immediate clarity poses serious operational and financial risks. Many dispensaries are now unsure which products to pull from shelves, how to manage inventory losses, and whether they may face penalties for unintentionally selling recalled goods.
This uncertainty also threatens the credibility of the legal cannabis market, which continues to struggle against the unlicensed market’s dominance. Without a reliable compliance verification system, legitimate operators risk being caught in the fallout from enforcement actions they had no part in.
The events surrounding Omnium and the OCM’s enforcement illustrate a deeper issue facing regulated cannabis markets: the need for real-time transparency, verified traceability, and digital accountability.
Platforms like Qredible’s Q-Verify™ and Q-Monitor enable regulators, retailers, and suppliers to verify compliance through blockchain-secured documentation and automated monitoring. For cannabis businesses, this means every product, transaction, and license is validated and traceable—protecting operators from regulatory risk and safeguarding consumer trust.
Qredible’s ecosystem also supports retailers with digital Certificates of Analysis (COAs) through MyCOA®, ensuring all products on shelves meet state-mandated quality and safety standards. By providing automated verification and compliance tracking, Qredible helps dispensaries avoid costly recalls, maintain transparency with regulators, and strengthen trust with customers in an increasingly competitive market.
To learn how Qredible can help your cannabis business navigate compliance challenges, manage product verification, and build lasting consumer trust, connect with our team.
